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ABSTRACT
Objective: The purpose of this study was to analyze the ability of septicemic and nonsepticemic
isolates of group B streptococci (GBS) to inhibit in vitro the principal bacterial groups found in the
normal bacterial flora of the female genital tract.
Methods: The target groups were composed of 1) 10 strains each of the following: viridans
streptococci, nonhemolytic streptococci (not group B or D), groupA streptococci, GBS, peptostrep-
tococci, coagulase-negative staphylococci, Staphylococcus aureus, and Gardnerella vaginalis; 2) 9
strains of enterococci; 3)9 strains ofgroup C orG streptococci; 4) 7 strains of lactobacilli; and 5) 7
strains ofdiphtheroids. All target groups were tested for inhibition by a test panel ofeither a group of
10 or 41 GBS isolates. If theGBS isolates failed to inhibit a target group, that group was tested for its
ability to inhibit the GBS test panel.
Results: The GBS test panel did not inhibit the growth of coagulase-negative staphylococci or S.
aureus but uniformly inhibited groups A, B, C, andG streptococci, lactobacilli, and G. vaginalis. One
of the 7 strains of diphtheroids was inhibited by 37 of the 41 GBS isolates; the other 6 strains of
diphtheroids were uniformly inhibited. Variable inhibition by GBS was observed with viridans
streptococci, nonhemolytic (not group B or D) streptococci, peptostreptococci, and enterococci;
however, inhibition or noninhibition was uniform for a given target strain against the entireGBS test
panel. The 23 GBS isolates obtained from septicemic neonates or adults did not differ from the 18
nonsepticemic isolates in their ability to inhibit other species ofstreptococci or other gram-positive or
gram-variable constituents of the bacterial flora of the female genital tract. When converse testing
was done, all 10 GBS isolates were uniformly inhibited by coagulase-negative staphylococci and by
the majority of enterococci, but were not inhibited by S. aureus.
Conclusions: These studies suggest that GBS may be significant regulators of other [3-hemolytic
streptococci, diphtheroids, lactobacilli, and G. vaginalis within the bacterial flora of the female
genital tract. Moreover, the absence ofGBS in the vaginal flora may be the result of mediation by
coagulase-negative staphylococci and selected strains ofenterococci. (C) 1995 Wiley-Liss, Inc.
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hen quantitative and qualitative bacteriolog-
ical studies are performed on the normal
bacterial flora of the cervical and vaginal vault, the
dominant aerobic groups of bacteria are lactoba-
cilli, diphtheroids, staphylococci, streptococci, and
occasionally members ofEnterobacteriaceae.
1-6 The
dominant anaerobic groups are composed of gram-
positive bacilli which include lactobacilli, pep-
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tostreptococci (which now incorporate peptococci),
and Bacteroidaceae. Group B streptococci (GBS)
constitute a potentially important subgroup within
the streptococci. Not only are they frequent inhab-
itants of the bacterial flora of the female genital
tract, but they are also the most common endoge-
nous cause of monomicrobial disease for both par-
turitional gravidas and neonates.
7-1 The mecha-
nisms that determine their presence, dominance, or
exclusion are poorly delineated.
This study was carried out to analyze the ability
of 23 isolates of GBS derived from septicemia pa-
tients and 18 isolates ofGBS derived from vaginal
specimens to inhibit other gram-positive or gram-
variable bacteria that may be constituents of the
bacterial flora of the female genital tract.
MATERIALS AND METHODS
Strains
The isolates of streptococci were provided by Mi-
crobiology Laboratory at St. Joseph Hospital,
Omaha, NE; Gail Hill, Ph.D., Duke University
School of Medicine, Durham, NC; Jon Rosen-
blatt, M.D., Mayo Clinic, Rochester, MN; Chris-
tine C. Sanders, Ph.D., Creighton University
School of Medicine, Omaha, NE; and David F.
Welch, M.D., University of Oklahoma College
of Medicine, Oklahoma City, OK.
Initially, an inhibitor test panel of 41 isolates of
GBS was examined. These inhibitor isolates were
tested against target cultures of other streptococci
and aerobic bacteria common in the vaginal flora.
Twenty-three of the 41 isolates of GBS were ob-
tained from blood cultures of septicemic patients.
Of these 23 isolates, 15 were obtained from infants
with early-onset or late-onset GBS disease, and the
remaining were obtained randomly from other
sources. Because of the uniformity of inhibition
observed with the entire 41 isolates of GBS in the
early experiments, the inhibitor test panel was sub-
sequently reduced to 10 isolates of GBS. Of these
10 GBS isolates, 5 were derived from cases of
early-onset neonatal septicemia and 5 were derived
from incidental female-genital-tract cultures.
The target cultures included 10 viridans strepto-
cocci, 10 GBS, 10 nonhemolytic streptococci (not
group B or D), 10 group A streptococci, 9 group C
or G streptococci, 10 peptostreptococci, 9 entero-
cocci, 10 coagulase-negative staphylococci, 10 Sta-
phylococcus aureus, 7 lactobacilli, 7 diphtheroids,
and 10 Gardnerella vaginalis. As an internal con-
trol, 10 target cultures ofEscherichia coli were tested
in 255 individual challenges to confirm the inabil-
ity ofGBS to inhibit gram-negative rods. The tar-
get sources of these cultures were vaginal isolates
obtained in previous studies by one of the authors
(G.R.G.M.).
Media
Trypticase soy agar (TSA) (Baltimore Biological
Laboratories, Baltimore, MD) was used for both
layers in the overlay procedure. The organisms
were maintained on TSA supplemented with
5% sheep blood (BAP, Scott Laboratories,
Fiskeville, RI).
Maintenance
All aerobic bacteria were subcultured to fresh BAP
every 2 weeks, incubated for 24 h at 35C in 10%
CO2 in air, and then held at 4C. The anaerobic
streptococci were grown under anaerobic condi-
tions.
Overlay Assay
A modification of the technique described by Fred-
ericq
11 and further developed by Crow et al.
12 and
Murray and Rosenblatt
13 was used for the overlay
assays. Each strain of GBS was inoculated onto a
1-cm
2 area of a 15-ml TSA plate. Four strains per
plate were tested. The organisms were incubated
for 18-24 h in 10% CO2 at 35C. They were
overlaid with 7.5 ml of molten TSA which was
allowed to solidify. The target strain was then inoc-
ulated onto the top of the fresh TSA in the follow-
ing manner. A 0.40D at 450 nm of the target
strain was prepared in physiological saline. A 1:10
dilution was prepared in saline and a 2-ml quantity
was inoculated onto the freshly overlaid plate. The
excess was siphoned off, and the plates were incu-
bated for 24 h at 35C in 10% CO2. The assays
were performed in duplicate. After incubation, the
assays were examined for inhibition of growth of
the target strain (Fig. 1). The stab/chloroform tech-
nique was used for confirmation of inhibition, lz
RESULTS
Viridans Streptococci
Seven strains of viridans streptococci were inhib-
ited by all GBS strains examined in 101 tests (Table
1). Three viridans streptococci isolates were not
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Group C or G Streptococci
For the 9 challenge strains of group C (7) and
group G (2) streptococci, inhibition was complete
in all 183 challenge experiments (Table 1).
Peptostreptococci
Of the 10 peptostreptococci, 7 challenge isolates
were inhibited completely. Three of the 10 were
not inhibited. The target isolates exhibited a uni-
form pattern of inhibition or noninhibition by GBS.
The presence or absence of inhibition for the indi-
vidual species of peptostreptococci is listed in Ta-
ble 2.
Fig. I. Demonstration of bacterial interference by GBS.
The lawn of the target isolate shows inhibition of growth in
the central area of streaking of the inhibitor strain under-
neath.
inhibited by the GBS test panel. When inhibition
was observed, the phenomenon was produced by
the entire panel of 10 or 41 GBS.
Nonhemolytic Streptococci
(Not Group B or D)
Of the 10 target strains of the nonhemolytic strep-
tococci (not group B or D), 9 isolates were inhib-
ited by GBS. Comparable inhibition was produced
by all of the GBS tested (Table 1).
Enterococci
Of the 9 strains of enterococci, only isolate was
inhibited by GBS (Table 1). Although the results
were uniform for both inhibition and noninhibi-
tion for the entire GBS panel, the degree of inhibi-
tion varied from isolate to isolate. When 5 strains
of the enterococci were used as the inhibitor strain,
all 10 isolates of the GBS tested in 50 challenge
experiments were inhibited.
Group A Streptococci
All 10 target strains of group A streptococci were
inhibited by GBS in 193 challenge experiments
(Table 1).
GBS
For the 10 target strains of GBS, inhibition was
complete in 193 challenge experiments (Table 1).
Coagulase-Negative Staphylococci
None of the 10 target isolates of coagulase-negative
staphylococci tested in 193 individual challenge ex-
periments was inhibited by GBS (Table 1). When
5 strains of coagulase-negative staphylococci were
used as inhibitors, all 10 of the group of GBS
isolates in 50 challenge experiments were inhibited.
S. aureus
None of the 10 target isolates of S. aureus in 193
individual challenge experiments was inhibited by
GBS (Table 1). When 5 strains of S. aureus were
used as inhibitor cultures, none of the 10 GBS was
inhibited in 50 challenge experiments.
Lactobacilli
All 7 target isolates of lactobacilli were inhibited in
163 individual challenge experiments (Table 1).
Diphtheroids
All 7 target isolates of diphtheroids tested individ-
ually were inhibited by GBS. One isolate had a
variable pattern of inhibition so that, of the 194
individual experiments, 190 showed inhibition (Ta-
ble 1).
G. vaginalis
All 10 target isolates of G. vaginalis were inhibited
by GBS in 193 individual challenge experiments
(Table 1).
DISCUSSION
The initial concept of bacterial interference ema-
nated from the observations of Pasteur and
Joubert.
14 They noted that Bacillus anthracis in
urine cultures would die if contaminated by other
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TABLE I. Inhibition of target bacteria by GBS isolates
No. of strains/
No. of strains No. of (No. of observations)
Target bacteria tested observations Inhibited Noninhibited
Viridans streptococci 10
Nonhemolytic streptococci 10
(not group B or D)
Enterococci 9
Group A streptococci 10
GBS 10
Group C (7) or G (2) streptococci 9
Peptostreptococci 0
Coagulase-negative staphylococci 10
S. aureus 10
Lactobacilli 7
Diphtheroids 7
G. vaginalis 0
193 7/(101) 3/(92)
9 9/(8) /(0)
276 I/(41) 8/(235)
193 10/(193) 0/(193)
193 10/(193) 0/(193)
183 9/(183) 0/(183)
193 7/(132) 3/(61)
93 0/(93) 0/(93)
93 0/(93) 0/(93)
163 7/(163) 0/(163)
93 7/(86) 0/(4)
93 0/(93) 0/(93)
aFour of GBS in the panel of isolate were inhibitory.
TABLE 2. In vitro bacterial interference by GBS on
10 strains of peptostreptococci
Individual
peptostreptococcal No. of test
isolates strains of GBS % Inhibition
P. tetradius 0 O0
10 0
P. anaerobius 41 100
10 100
10 100
P. micros 41 100
10 0
P. asaccharolyticus 41 0
10 100
10 100
bacteria. The mechanisms by which a bacterial spe-
cies maintains its ecological niche are varied. In-
hibitor bacterial products include a wide range of
substances: low-molecular-weight antibiotics, met-
abolic products, hydrogen peroxide, lytic agents,
enzymes, bacteriocins, and bacteriophages.
15,16
The ultimate question for GBS is how this normal
constituent of the bacterial flora of the female geni-
tal tract survives or governs. These studies ls’16
demonstrate that GBS have the ability, through
bacterial interference, to defend their ecological
niches in vitro, not only against other GBS but also
against [3-hemolytic strains of group A, C, and G
streptococci. This ability appears to be uniform,
which may be the result of a genetic interrelation-
ship between hemolytic activity and bacterial inter-
ference. Brock et al. found that, by categorizing
strains of S. zymogens in terms of their hemolytic
character, they could demonstrate uniform bacte-
rial interference mediated by bacteriocins.
17 In their
study, they found no variation in the ability ofGBS
to inhibit bacterial replication between septicemic
and nonsepticemic GBS isolates. In our study, no
differences in inhibition or noninhibition were iden-
tified between septicemic isolates from incidental
vaginal cultures. The primary risk factors that ac-
count for a statistically significant increase in the
anticipated incidence of GBS diseases in neonates
are related to their ability to colonize the urinary
tract (bacteriuria) and to achieve high-density rep-
lication within the vaginal and rectal bacterial
flora.
18
Based on preliminary observations, other inves-
tigators have reported that heavy-density coloniza-
tion is due primarily to the avid ability of" selected
strains of beta hemolytic streptococci to adhere to
genitourinary epithelial cells rather than to a unique
ability to regulate the associated vaginal flora iv,
Reed et al. looked at group A streptococcal adher-
ence to pharyngeal cells in isolates from cases of"
acute rheumatic fever isolates. They found that
streptococci strains associated with acute rheumatic
fever appeared to adhere more avidly to pharyngeal
cells than strains not associated with rheumatic
fever.
The potential of GBS to govern the enterococci
is significant. The majority of isolates (9 5%) exhib-
ited complete inhibition. The impact of GBS on
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NO, INHIBITION COMPLETE INHIBITION
Entembacteriaceae
Coagulase-negative staphylococci
StaohvIococcus aureus
GROUP B
STREPTOCOCCI
Other group B streptococci
Group A, C, G streptococci
Gardnerella vac=inalis
lactobacilli
diphtheroids
MINORITY OF STRAINS
INHIBITED
Enterococci
MAJORITY OF
STRAINS INHIBITED
viridans streptococci (70%)
Non-B, non-D
streptococci exhibiting
no hemolysis (90%)
Peptostreptococci (63%)
Fig. 2. Schematic representation of the ability of GBS to inhibit replication of streptococci and
nonstreptococcal aerobic bacteria endogenous to the bacterial flora of the female genital tract.
viridans streptococci, enterococci, and peptostrep-
tococci was significantly less. GBS inhibited other
common nonstreptococcal gram-positive aerobic
bacteria and G. vaginalis but had no impact on
staphylococci. These observations, along with those
of other studies in the literature, may provide in-
sight regarding the bacterial interrelationships
within the bacterial flora of the female genital tract.
Traditionally, the dominance of lactobacilli has
been thought to correlate with the normality of the
vaginal bacterial flora. De Klerk and Coetzec stud-
ied bacterial inhibition by lactobacilli. Using su-
pernatants concentrated by ammonium-sulfate
precipitators, they were able to demonstrate an
antibacterial spectrum that was primarily restricted
to certain members of the family Lactobacteri-
aceae.
2 A significant number of enterococci were
inhibited. The antibiotic-like supernatants had no
impact upon the Enterobacteriaceae or staphylo-
cocci. Holmberg and Hallander documented the
ability of Streptococcus sanguis to inhibit Lacto-
bacillus acidophilus, L. fermentum, and L. casei.
22
Phonck, among others, also demonstrated the abil-
ity of streptococci to inhibit vaginal lactobacilli.
23
The importance of lactobacilli may be more their
role as regulators of enterococci than as major reg-
ulators of GBS.
Statistically, coagulase-negative staphylococci are
more frequently present in the bacterial flora than
Staphylococcus aureus.
-4 Both coagulase-negative
and coagulase-positive staphylococci have signifi-
cant ability to inhibit other bacteria. Possibly more
important is their insensitivity to bacterial interfer-
ence by other constituents of the bacterial flora.
Dajani and Wannamaker
24 demonstrated the abil-
ity of S. aureus to produce a bactericidal substance
that inhibits group A, D, and G streptococci. Ob-
servations in clinical disease in which both staphy-
lococci and 13-hemolytic streptococci can be con-
comitantly isolated from skin lesions have raised
questions as to whether staphylococci invade sites
previously infected with [3-hemolytic organisms or
a significant coupling occurs between the 2 groups
of gram-positive bacteria.
24-27 Theoretically, S.
aureus as the dominant staphylococcal species may
occur either directly (by insensitivity to bacterial
interference) or indirectly. Anaerobic bacteria (par-
ticularly Bacteroides melaninogenicus and B. fragilis)
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can counter the inhibition of coagulase-negative
staphylococci, thereby allowing S. aureus to occupy
the void.
The ability of a given strain of Enterobacteri-
aceae to inhibit other members of the family has
been well documented.
16 The predominance of a
strain of E. coli as the principal Enterobacteriaceae
in the bacterial flora may also be the result of Bac-
teroidaceae’s inhibition of competing strains. Mur-
ray and Rosenblatt13 demonstrated that B. melani-
nogenicus, B. fragilis, and B. oralis, while possessing
significant ability to inhibit Enterobacter cloacae,
E. aerogenes, Klebsiella species, and Serratia
marcescens, were ineffective against E. coli and
Morganella morganii. Bacteroidaceae had moderate
inhibitor activity against coagulase-negative staphy-
lococci but almost no activity against S. aureus. In
their report, fusobacteria and L. fermentum had
little inhibitory effect on either gram-negative or
gram-positive bacteria. Interspecies governance
among the Enterobacteriaceae is probably mediated
by bacteriocins, but the predominance of E. coli
and Proteus mirabilis may be a direct function of
their resistance to bacterial inhibition by Bacte-
roidaceae.
Our demonstration of the in vitro ability ofGBS
to inhibit streptococci, lactobacilli, diphtheroids,
G. vaginalis, and most hemolytic and nonhemolytic
streptococci infers that GBS may be significant reg-
ulators of the bacterial flora of the female genital
tract (Fig. 2). The presence of GBS in the vaginal
flora may be determined by the absence of coagu-
lase-negative staphylococci or selected strains of en-
terococci. The studies of bacterial inhibition in the
literature, coupled with the present observations,
infer that the ability of GBS to participate in pro-
gressive polymicrobial anaerobic infection may re-
sult as a consequence of the inhibition of coagulase-
negative staphylococci by Bacteroidaceae.
28
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